StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS – Get Free Report) in a research report issued to clients and investors on Friday. The brokerage set a “hold” rating on the stock.
Milestone Scientific Stock Performance
Shares of Milestone Scientific stock opened at $0.66 on Friday. Milestone Scientific has a 12-month low of $0.52 and a 12-month high of $1.35. The firm has a market capitalization of $50.97 million, a price-to-earnings ratio of -6.60 and a beta of 0.89. The firm’s 50 day simple moving average is $0.70 and its two-hundred day simple moving average is $0.66.
Milestone Scientific (NYSE:MLSS – Get Free Report) last issued its quarterly earnings results on Wednesday, May 15th. The company reported ($0.02) earnings per share (EPS) for the quarter. The company had revenue of $2.25 million for the quarter. Milestone Scientific had a negative net margin of 74.50% and a negative return on equity of 93.64%.
About Milestone Scientific
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
See Also
- Five stocks we like better than Milestone Scientific
- Low PE Growth Stocks: Unlocking Investment Opportunities
- MarketBeat Week in Review – 7/1 – 7/5
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Constellation Brands Stock Q1 2025: Crushing Anheuser-Busch?
- Insider Trades May Not Tell You What You Think
- Qualcomm Stock Continues to Rise in the Face of Negative News
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
